FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/11/010645 [Registered on: 27/11/2017] Trial Registered Prospectively
Last Modified On: 15/11/2019
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [40% dextrose gel application over buccal mucosa]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Prevention of low blood sugar by 40% Oral Dextrose gel in newborn infant of diabetic mother 
Scientific Title of Study   Role of 40% oral dextrose gel on prevention of hypoglycemia in newborn Infants of Diabetic Mother (IDM) – A Randomized Controlled Trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Thanigainathan 
Designation  Assistant Professor 
Affiliation  Christian Medical College 
Address  Assistant Professor, Neonatology Department, Christian Medical College, Vellore, Tamil nadu, India.
Assistant Professor, Neonatology Department, Christian Medical College, Vellore, Tamil nadu, India.
Vellore
TAMIL NADU
632004
India 
Phone  9176078520  
Fax    
Email  thanigaipaeds@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Thanigainathan 
Designation  Assistant Professor 
Affiliation  Christian Medical College 
Address  Assistant Professor, Neonatology Department, Christian Medical College, Vellore, Tamil nadu, India.
Assistant Professor, Neonatology Department, Christian Medical College, Vellore, Tamil nadu, India.
Vellore
TAMIL NADU
632004
India 
Phone  9176078520  
Fax    
Email  thanigaipaeds@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Thanigainathan 
Designation  Assistant Professor 
Affiliation  Christian Medical College 
Address  Assistant Professor, Neonatology Department, Christian Medical College, Vellore, Tamil nadu, India.
Assistant Professor, Neonatology Department, Christian Medical College, Vellore, Tamil nadu, India.
Vellore
TAMIL NADU
632004
India 
Phone  9176078520  
Fax    
Email  thanigaipaeds@yahoo.com  
 
Source of Monetary or Material Support  
Christian Medical College, Vellore, India. 
 
Primary Sponsor  
Name  Christian Medical College 
Address  Vellore, Tamilnadu, Vellore. 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Sivam Thanigainathan  Christian Medical College  Department of Neonatology, Christian Medical College, Vellore.
Vellore
TAMIL NADU 
9176078520

thanigaipaeds@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Christian Medical College Ethical committee,vellore, India.  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Infant of diabetic mother more than 35 weeks of gestational age and more than 2 kg.,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  40% dextrose gel  1.Strict thermoregulation in delivery room (NRP recommendation) 2.Apply oral dextrose gel 200mg/kg over buccal mucosa 3.Start Direct breast feeding (within 30 mins) 4.Every feed should be not less than 20 minutes 5.First GRBS measurement at one and half an hour 6.Continue Direct breast feed (DBF) Q2-3Hourly 7.If baby not suck at breast 5 ml/kg of expressed colostrum will be given to term babies (If colostrum not available, 2:1 will be given) and 3.5 ml/kg of expressed colostrum will be given to preterm babies. 8.Monitor temperature at 1 hour of life followed by 6th hourly. 
Comparator Agent  No dextrose gel  1.Strict thermoregulation in delivery room (NRP recommendation) 2.Start Direct breast feeding (within 30 mins) 3.Every feed should be not less than 20 minutes 4.First GRBS measurement at one and half an hour 5.Continue Direct breast feed (DBF) Q2-3Hourly 6.If baby not suck at breast 5 ml/kg of expressed colostrum will be given to term babies (If colostrum not available, 2:1 will be given) and 3.5 ml/kg of expressed colostrum will be given to preterm babies. 7.Monitor temperature at 1 hour of life followed by 6th hourly. 
 
Inclusion Criteria  
Age From  0.00 Day(s)
Age To  1.00 Day(s)
Gender  Both 
Details  Infant of diabetic mother more than 35 weeks of gestational age and more than 2 kg. 
 
ExclusionCriteria 
Details  1. Requiring admission before randomization (preterm neonates less the 35 weeks of gestational age, birth weight less than 2000 grams, respiratory distress, major lethal congenital malformation, antenatal ultrasound findings with absent/reversal of end diastolic mesenteric flow, Rh negative mother with DCT positive baby and indication suggested by consultants).
2. No consent
3. Major congenital malformation 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Incidence of hypoglycemia   in the first 24 hours after birth 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in admission rate due to hypoglycemia
 
in the first 24 hours after birth 
Formulation of scoring system to predict the responder and non-responder to oral dextrose gel based on following risk factors:
Type of maternal diabetes
Uncontrolled maternal diabetes
Placentomegaly
cord blood glucose
cord blood C peptide level
rate of fall of blood glucose at one and half an hour
SGA
LGA
macrosomia
IUGR
prematurity
low birth weight
PIH
maternal use of beta blocker and dextrose containing IV fluids during labor
cold stress
hypothermia 
one and half an hour of life 
Duration of hospital stay  within 28 days of life 
Maximum requirement of Glucose Infusion Rate  till 24 hours of life 
Incidence of rebound hypoglycemia  till 24 hours of life 
Incidence of hyperglycemia   till 24 hours of life 
Incidence of late hypoglycemia  till 24 hours of life 
Rate of exclusive breast feeding till discharge determined by parental
Questionnaire 
till discharge 
Incidence of feed intolerance  till 24 hours of life 
Incidence of Necrotizing Enterocolitis  till 24 hours of life 
Incidence of sepsis without antenatal risk of sepsis  till discharge 
Number Needed to Treat  till 24 hours of life 
Compliance of care  till 24 hours of life 
Maternal satisfaction  till discharge 
Onset of action and duration of action of oral dextrose gel  till 24 hours of life 
Rate of rise of glucose due to oral dextrose gel  till 24 hours of life 
Rate of exclusive breast feeding up to 6 months of age  6 months of life 
 
Target Sample Size   Total Sample Size="600"
Sample Size from India="600" 
Final Enrollment numbers achieved (Total)= "611"
Final Enrollment numbers achieved (India)="611" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/12/2017 
Date of Study Completion (India) 23/10/2019 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   not published 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary      Infant of diabetic mother babies are more prone for hypoglycemia. Hypoglycemia causes neonatal morbidity and mortality. Few simple and low cost strategies such as early breast feeding, prolonged breast feeding for more than 20 minutes, frequent feeding every 2-3 hourly and strict thermoregulation in delivery room were studied and found that those interventions decrease the incidence of hypoglycemia in infant of diabetic mother babies and were accepted as standard of care. Recent research with 40% oral dextrose gel also had given promising results in reduction of incidence of hypoglycemia in at risk babies (IDM+SGA+preterm>35 weeks). We planned to study the add on beneficial effect of oral dextrose gel on prevention of hypoglycemia in infant of diabetic mother. 
  We plan a study with the aim of, "To study the prophylactic effect of 40% oral dextrose gel on prevention of neonatal hypoglycemia in infants of diabetic mother and to formulate a scoring system to predict the responder and non responder to 40% oral dextrose gel". 
  All mothers will be conselled for the importance of early, frequent & prolonged colostrum feeding. We will send the cord blood glucose and cord blood marker of high insulin level (C peptide) in Infant of diabetic mother (IDM ) babies.  We will apply 200mg/kg of 40% oral dextrose gel within 30 minutes of life in study group followed by breast feeding and only breast feeding without gel in control group. 
  We will measure the blood glucose level in both the groups at 11/2 , 3, 5, 7, 12 , 18, 24 hour of life. We will measure the beneficial action of oral dextrose gel in the form of reduction in incidence of hypoglycemia, requirement of intravenous fluid, admission, not decrease the rate of exclusive breast feeding without causing any harm effect like hyperglycemia, late hypoglycemia and rebound hypoglycemia. We will try to formulate a scoring system to predict the responder and non responder to oral dextrose gel. Also we will find out few pharmacokinetic properties of 40% oral dextrose gel like onset of action, duration of action and rate of rise of blood glucose. 
 
Close